Androgen receptor as a therapeutic target

Area of Science:

• Endocrinology and pharmacology
• Molecular biology
• Drug discovery

Background:

• Androgens are sex hormones that activate the androgen receptor (AR, or NR3C4).
• AR is a key therapeutic target for conditions like hypogonadism and prostate cancer.
• Current AR ligands bind directly to the AR ligand-binding pocket (LBP) to modulate function.

Purpose of the Study:

• To review current therapeutic applications of AR ligands.
• To discuss challenges in AR ligand development.
• To explore novel strategies for future AR ligand drug development.

Main Methods:

• Literature review of AR structure and function.
• Analysis of AR ligand mechanisms of action.
• Examination of tissue-selective AR ligand development.

Main Results:

• Significant progress in understanding AR structure and function over the past decade.
• Development of newer generation AR ligands, including tissue-selective options.
• Tissue selectivity is expected to broaden therapeutic applications of AR ligands.

Conclusions:

• AR ligands are vital for treating AR-related diseases.
• Advances in AR knowledge facilitate the development of improved therapeutics.
• Future AR ligands with enhanced tissue selectivity hold significant therapeutic promise.